![]() |
市场调查报告书
商品编码
1395094
动物血液和血液成分市场 - 副产品(全血、红血球、白血球、血小板、血浆)、动物(大型、小型)、应用(出血、手术、癌症治疗、出血性疾病)、最终用户(医院、血库) ) , 2023 年全球预测Animal Blood & Blood Components Market - By Product (Whole Blood, RBC, WBC, Platelet, Plasma), Animal (Large, Small), Application (Hemorrhage, Surgery, Cancer Treatment, Bleeding Disorders), End-User (Hospital, Blood Bank), Global Forecast 2023 |
由于宠物主人越来越多地为他们的动物寻求全面的医疗保健服务,包括手术、治疗和疗法,预计动物血液和血液成分市场在 2023 年和 2032 年的CAGR将超过 9.7%。
动物的传染病和慢性疾病增加,可能需要输血来支持治疗方案。根据世界卫生组织 2023 年发布的报告,全球报告的新兴传染病中约 60% 源自动物,涵盖野生和家养物种。在过去的三十年里,已经发现了 30 多种新的人类病原体,其中 75% 来自动物。该组织的「同一个健康」计划专注于透过整合而不是分离这些系统来优化动物、人类和生态系统的健康。此类措施将刺激产品需求。
整个动物血液和血液成分市场根据产品、动物类型、应用、最终用户和地区进行分类。
血浆产品领域预计在 2023 年和 2032 年将显着增长,因为它富含凝血因子和抗体等必需成分。动物疾病盛行率不断上升,需要利用血浆衍生疗法。这在紧急情况下尤其明显,因为紧急情况的重点是有效满足医疗保健需求。
动物血液和血液成分产业的癌症治疗应用预计到 2032 年将产生高收入。随着动物癌症诊断变得越来越普遍,对包括化疗和放射治疗在内的专门治疗的需求不断增加。动物血液和血液成分含有重要元素,在支持这些干预措施方面发挥着至关重要的作用,有助于加强护理和改善结果。
在旨在提高动物保健标准的政府倡议和专业兽医服务兴起的支持下,亚太地区动物血液和血液成分市场将在 2023 年至 2032 年呈现令人印象深刻的成长趋势。该地区动物种群多样化,包括伴侣动物和牲畜,扩大了对各种血液製品的需求。创新兽医技术的采用以及对动物输血益处的日益认识将在未来几年继续影响亚太地区的市场动态。
Animal Blood & Blood Components Market is estimated to register a CAGR of over 9.7% during 2023 and 2032, as pet owners are increasingly seeking comprehensive healthcare services for their animals, including surgeries, treatments, and therapies.
There is a rise in infectious and chronic diseases among animals which may require blood transfusions to support treatment protocols. According to a report by World Health Organization published in 2023, approximately 60% of globally reported emerging infectious diseases stem from animals, spanning both wild and domestic species. Within the past three decades, over 30 new human pathogens have been identified, with 75% of these originating from animal sources. The One Health program by the organization focuses on optimizing the health of animals, humans, and ecosystems by integrating these systems, rather than separating them. Such initiative will boost the product demand.
The overall animal blood & blood components market is classified based on product, animal type, application, end-user, and region.
Plasma product segment is poised for a notable growth during 2023 and 2032, as it is rich in essential components such as clotting factors and antibodies. The rising prevalence of diseases in animals necessitates the utilization of plasma-derived therapies. This is particularly evident in emergency situations where the focus in on efficiently meeting the healthcare needs.
Cancer treatment application of animal blood & blood components industry is anticipated to generate high revenues by 2032. As cancer diagnoses in animals become more prevalent, there is an escalating demand for specialized treatments, including chemotherapy and radiation therapy. Animal blood and blood components, having vital elements, play a crucial role in supporting these interventions, contributing to enhanced care and improved outcomes.
Asia Pacific animal blood and blood components market will showcase impressive growth trends over 2023-2032, backed by the governmental initiatives aimed at enhancing animal healthcare standards and the rise of specialized veterinary services. The diverse animal population across the region, encompassing both companion animals and livestock, amplifies the demand for a wide range of blood products. Adoption of innovative veterinary technologies and a burgeoning awareness of the benefits associated with animal blood transfusions will continue to shape the market dynamics in the APAC region in the coming years.